SkyePharma’s asthma drug gets European marketing nod – Reuters

SkyePharma's asthma drug gets European marketing nod
Reuters
Company sees launching drug across Europe in H2* Stock up 28 pct, top percentage gainer on LSEJuly 3 (Reuters) – Britain's SkyePharma Plc said itsasthma therapy Flutiform got marketing approval from.

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.